Vivanza Biosciences Q2 Results
- BSE: 530057
- NSE: -
- ISIN: INE984E01035
- Sector: Biotechnology & Drugs
BSE
2.09
0.10 (5.03%)
0.10 (5.03%)Volume9.89 K
Updated: Fri 10 Apr, 2026 | 15:15:00
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Vivanza Biosciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 54.76 | 8.79 | 522.72% | 2.90 | 1791.05% |
| Depreciation/ Amortization | 0.00 | 0.00 | 0.00% | 0.00 | -14.63% |
| Operating Income | 0.60 | 0.15 | 312.04% | 0.11 | 473.17% |
| Net Income | 0.56 | 0.09 | 547.01% | 0.02 | 3531.61% |
| Other Operating Expenses Total | 0.07 | 0.10 | -30.54% | 0.04 | 65.59% |
| Net Income Before Taxes | 0.56 | 0.09 | 547.01% | 0.02 | 3531.61% |
| Total Revenue | 55.36 | 8.94 | 519.27% | 3.00 | 1744.89% |
| Selling/ General/ Admin Expenses Total | 0.25 | 0.14 | 81.96% | 0.14 | 80.77% |
| Diluted Normalized EPS | 0.14 | 0.02 | 600.00% | 0.00 | 3508.25% |